31 completed. 30 Phase 1, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 30 | Completed 30 |
| Not applicable | 1 | Completed 1 |
Follow IPCA Laboratories Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bioequivalence Study of Metoprolol Succinate Extended Release Tablets 50 mg Metoprolol Succinate ER Tablets 50 mg, 'TOPROL-XL®' ER Tablets 50 mg - Fasting | Phase 1 | Completed | IPCA Laboratories Ltd. | 48 | 2013-04-01 | 2013-06-24 |
| Bioequivalence Study of Metoprolol Succinate Extended Release Tablets 200 mg Under Fed Conditions Metoprolol Succinate ER Tablet 200 mg, 'TOPROL-XL®' ER Tablets 200 mg - Fed | Phase 1 | Completed | IPCA Laboratories Ltd. | 48 | 2013-04-01 | 2013-06-24 |
| Bioequivalence Study of Metoprolol Succinate Extended Release Tablets 200 mg Under Fasting Conditions Metoprolol Succinate ER Tablet 200 mg, 'TOPROL-XL®' ER Tablets 200 mg - Fasting | Phase 1 | Completed | IPCA Laboratories Ltd. | 48 | 2013-02-01 | 2013-06-24 |
| Bioequivalence Study of Metformin Hydrochloride Extended-Release Tablets USP 750 mg Under Fed Condition Metformin Hydrochloride Extended-Release Tablets USP 750, GLUCOPHAGE®XR tablet 750 mg - Fasting | Phase 1 | Completed | IPCA Laboratories Ltd. | 48 | 2012-12-01 | 2013-04-15 |
| Bioequivalence Study of Metformin Hydrochloride Extended-Release Tablets USP 750 mg Under Fasting Condition Metformin Hydrochloride Extended-Release Tablets USP 750 mg, GLUCOPHAGE®XR - Fasting | Phase 1 | Completed | IPCA Laboratories Ltd. | 48 | 2012-12-01 | 2013-04-15 |
| Bioequivalence Study of Etodolac Extended Release Tablets USP 600mg Under Fed Condition Etodolac Extended Release Tablets USP 600mg, Etodolac Extended Release Tablets 600mg - Fasting | Phase 1 | Completed | IPCA Laboratories Ltd. | 36 | 2012-12-01 | 2013-04-15 |
| Bioequivalence Study of Etodolac Extended Release Tablets USP 600mg Under Fasting Condition Etodolac Extended Release Tablets USP 600mg, Etodolac Extended Release Tablets 600mg - Fasting | Phase 1 | Completed | IPCA Laboratories Ltd. | 36 | 2012-11-01 | 2013-04-10 |
| Bioequivalence Study of Lisinopril and Hydrochlorothiazide Tablets (20+25) mg Under Fed Conditions Lisinopril and Hydrochlorothiazide Tablets (20+25) mg, Zestoretic® 20/25 lisinopril/hydrochlorothiazide Tablets - Fed | Phase 1 | Completed | IPCA Laboratories Ltd. | 48 | 2012-10-01 | 2013-04-10 |
| Bioequivalence Study of Lisinopril and Hydrochlorothiazide Tablets (20+25) mg Under Fasting Conditions Lisinopril and Hydrochlorothiazide Tablets (20+25) mg, Zestoretic® 20/25 lisinopril/hydrochlorothiazide Tablets - Fasting | Phase 1 | Completed | IPCA Laboratories Ltd. | 48 | 2012-10-01 | 2013-04-15 |
| Bioequivalence Study of Etodolac Capsules USP 300 mg Under Fed Condition Etodolac Capsules USP 300 mg, Etodolac - Healthy | Phase 1 | Completed | IPCA Laboratories Ltd. | 36 | 2012-10-01 | 2012-12-13 |
| Bioequivalence Study of Etodolac Capsules USP 300 mg Under Fasting Condition Etodolac Capsules USP 300 mg, Etodolac - Fasting | Phase 1 | Completed | IPCA Laboratories Ltd. | 36 | 2012-10-01 | 2012-12-11 |
| Bioequivalence Study of Bisoprolol Fumarate Tablet 10 mg Under Fasting Condition Bisoprolol Fumarate Tablet 10 mg, Bisoprolol - Fasting | Phase 1 | Completed | IPCA Laboratories Ltd. | 24 | 2012-08-01 | 2012-12-05 |
| Bioequivalence Study of Bisoprolol Fumarate Tablet 10 mg Under Fed Condition Bisoprolol Fumarate Tablet 10 mg, Bisoprolol - Fed | Phase 1 | Completed | IPCA Laboratories Ltd. | 24 | 2012-08-01 | 2012-12-07 |
| Bioequivalence Study of Lisinopril Tablets 40 mg Under Fed Condition Lisinopril Tablets 40 mg, Lisinopril - Fed | Phase 1 | Completed | IPCA Laboratories Ltd. | 40 | 2012-06-01 | 2012-12-03 |
| Bioequivalence Study of Risperidone Tablet 1 mg Under Fasting Condition Risperidone Tablet 1 mg, Risperidone - Fasting | Phase 1 | Completed | IPCA Laboratories Ltd. | 48 | 2012-06-01 | 2012-11-06 |
| Bioequivalence Study of Lisinopril Tablets 40 mg Under Fasting Condition Lisinopril Tablets 40 mg, Lisinopril - Fasting | Phase 1 | Completed | IPCA Laboratories Ltd. | 40 | 2012-06-01 | 2012-12-03 |
| Bioequivalence Study of Etodolac Tablet USP 500 mg Under Fed Condition Etodolac Tablets USP 500mg, Etodolac Tablets USP 500 mg - Fed | Phase 1 | Completed | IPCA Laboratories Ltd. | 36 | 2012-05-01 | 2012-12-03 |
| Bioequivalence Study of Etodolac Tablet USP 500 mg Under Fasting Condition Etodolac Tablets USP 500mg, Etodolac Tablets USP 500 mg - Fasting | Phase 1 | Completed | IPCA Laboratories Ltd. | 36 | 2012-05-01 | 2012-12-03 |
| Bioequivalence Study of Risperidone Tablet 1 mg Under Fed Condition Risperidone Tablet 1 mg, Risperidone - Fed | Phase 1 | Completed | IPCA Laboratories Ltd. | 48 | 2012-05-01 | 2012-06-13 |
| Bioequivalence Study of Indomethacin Extended-Release Capsules 75 mg Under Fed Condition Indomethacin Extended-Release Capsules USP 75 mg, Indomethacin Extended Release Capsules USP 75 mg - Fed | Phase 1 | Completed | IPCA Laboratories Ltd. | 32 | 2012-04-01 | 2012-11-06 |
Showing 20 of 31. Sign in to see all of them.
Fasting (12) · Lecithin Cholesterol Acyltransferase Deficiency (12)
Etodolac (4) · Lisinopril (4) · Hydrochlorothiazide (3) · Metoprolol (3) · Bisoprolol (2) · Lamotrigine (2) · Ondansetron (2) · Quetiapine Fumarate (2) · Risperidone (2) · levocetirizine (2) · Allopurinol (1) · Carvedilol (1) · Tablets (1)
India (30)
Dr. Tarang Shah, M.D. (5) · Dr. Hardik Dave, M.B.B.S (4) · Dr. Hardik Dave, M.B.B.S. (4) · Dr. Rupesh Vala, M.B.B.S. (4) · Dr. Manish Singhal, MBBS (3) · Dr. Nirav Gandhi, M.D. (3) · Dr. Suhas Khandave, M.D. (3) · Dr. Manish Singhal, M.B.B.S (2) · Dr. Tarang Girishbhai Shah, M. D. (Pharmacology) (2)